Pathway Diagnostics: Biomarker Development, Testing and Commercialization Ask Us How

Press Releases

May 7, 2008
Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop™ II Molecular HIV Co-receptor Tropism Assay

November 15, 2007
Pathway Diagnostics Announces Patent issuance for the diagnostic measurement of HIV tropism for the initiation or modification of HIV therapy

October 26, 2007
Quest Licenses Pathway's SensiTrop™ Assay

October 3, 2007
Pathway Diagnostics Announces Commercial Availability of SensiTrop™ HIV Co-receptor Tropism Assay

July 17, 2007
Mayo Clinic Offers New Genetic Test to Help Manage Treatment for Patients with Depression

January 8, 2007
QIAGEN and Pathway Diagnostics Sign Agreement to Address Biomarker Development Needs in Pharma

What's New "Announcing SensiTrop™ II HIV co-receptor tropism assay, combining the sensitivity of heteroduplex tracking and the specificity of DNA sequence analysis "
©2007 PathwayDX.com. Privacy Policy.